These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7527577

  • 1. The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency.
    Ochs HD, Hollenbaugh D, Aruffo A.
    Res Immunol; 1994; 145(3):210-5; discussion 244-9. PubMed ID: 7527577
    [No Abstract] [Full Text] [Related]

  • 2. The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency.
    Ochs HD, Hollenbaugh D, Aruffo A.
    Semin Immunol; 1994 Oct; 6(5):337-41. PubMed ID: 7532462
    [Abstract] [Full Text] [Related]

  • 3. The molecular basis for T cell help in humoral immunity: CD40 and its ligand, gp39.
    Marshall LS, Aruffo A, Ledbetter JA, Noelle RJ.
    J Clin Immunol; 1993 May; 13(3):165-74. PubMed ID: 7686564
    [No Abstract] [Full Text] [Related]

  • 4. The role of CD40 and its ligand (gp39) in peripheral and central tolerance and its contribution to autoimmune disease.
    Durie FH, Foy TM, Noelle RJ.
    Res Immunol; 1994 May; 145(3):200-5; discussion 244-9. PubMed ID: 7527576
    [No Abstract] [Full Text] [Related]

  • 5. The expansive role of CD40 and its ligand, gp39, in immunity.
    Foy TM, Durie FH, Noelle RJ.
    Semin Immunol; 1994 Oct; 6(5):259-66. PubMed ID: 7532456
    [Abstract] [Full Text] [Related]

  • 6. Immunodeficiency due to a faulty interaction between T cells and B cells.
    Laman JD, Claassen E, Noelle RJ.
    Curr Opin Immunol; 1994 Aug; 6(4):636-41. PubMed ID: 7524537
    [Abstract] [Full Text] [Related]

  • 7. CD40 and its ligand in the regulation of humoral immunity.
    Klaus SJ, Berberich I, Shu G, Clark EA.
    Semin Immunol; 1994 Oct; 6(5):279-86. PubMed ID: 7532458
    [Abstract] [Full Text] [Related]

  • 8. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
    Foy TM, Shepherd DM, Durie FH, Aruffo A, Ledbetter JA, Noelle RJ.
    J Exp Med; 1993 Nov 01; 178(5):1567-75. PubMed ID: 7693850
    [Abstract] [Full Text] [Related]

  • 9. CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells.
    Aversa G, Punnonen J, Carballido JM, Cocks BG, de Vries JE.
    Semin Immunol; 1994 Oct 01; 6(5):295-301. PubMed ID: 7532459
    [Abstract] [Full Text] [Related]

  • 10. CD40-mediated regulation of human B-cell responses.
    Splawski JB, Lipsky PE.
    Res Immunol; 1994 Oct 01; 145(3):226-34; discussion 244-9. PubMed ID: 7527580
    [No Abstract] [Full Text] [Related]

  • 11. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.
    Farrington M, Grosmaire LS, Nonoyama S, Fischer SH, Hollenbaugh D, Ledbetter JA, Noelle RJ, Aruffo A, Ochs HD.
    Proc Natl Acad Sci U S A; 1994 Feb 01; 91(3):1099-103. PubMed ID: 7508119
    [Abstract] [Full Text] [Related]

  • 12. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.
    Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M.
    Cell; 1993 Jan 29; 72(2):291-300. PubMed ID: 7678782
    [Abstract] [Full Text] [Related]

  • 13. The role of CD40 in the regulation of humoral and cell-mediated immunity.
    Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ.
    Immunol Today; 1994 Sep 29; 15(9):406-11. PubMed ID: 7524518
    [Abstract] [Full Text] [Related]

  • 14. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J, de Rijk D, Kasran A, Barcy S, de Groot C, de Boer M.
    Eur J Immunol; 1994 Mar 29; 24(3):508-17. PubMed ID: 7510232
    [Abstract] [Full Text] [Related]

  • 15. In the absence of a CD40 signal, B cells are tolerogenic.
    Buhlmann JE, Foy TM, Aruffo A, Crassi KM, Ledbetter JA, Green WR, Xu JC, Shultz LD, Roopesian D, Flavell RA.
    Immunity; 1995 Jun 29; 2(6):645-53. PubMed ID: 7540943
    [Abstract] [Full Text] [Related]

  • 16. CD40 ligand and its role in X-linked hyper-IgM syndrome.
    Callard RE, Armitage RJ, Fanslow WC, Spriggs MK.
    Immunol Today; 1993 Nov 29; 14(11):559-64. PubMed ID: 7506037
    [Abstract] [Full Text] [Related]

  • 17. Hyper IgM syndrome: two mutations distinguish HIM.
    Foy TM, Masters SR, Noelle RJ.
    J Clin Invest; 1994 Oct 29; 94(4):1349-50. PubMed ID: 7523448
    [No Abstract] [Full Text] [Related]

  • 18. Functions of CD40 and Its Ligand, gp39 (CD40L).
    Laman JD, Claassen E, Noelle RJ.
    Crit Rev Immunol; 2017 Oct 29; 37(2-6):371-420. PubMed ID: 29773027
    [Abstract] [Full Text] [Related]

  • 19. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration.
    Nishioka Y, Lipsky PE.
    J Immunol; 1994 Aug 01; 153(3):1027-36. PubMed ID: 7517971
    [Abstract] [Full Text] [Related]

  • 20. Structural characteristics of CD40 ligand that determine biological function.
    Fanslow WC, Srinivasan S, Paxton R, Gibson MG, Spriggs MK, Armitage RJ.
    Semin Immunol; 1994 Oct 01; 6(5):267-78. PubMed ID: 7532457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.